You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, look for clinical trials, and connect with others living with it — all in one place.
Open the full Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate hub →Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate is a rare condition. Also known as Acute reversible leukoencephalopathy due to SLC13A3 deficiency, Acute reversible leukoencephalopathy due to sodium-dependent dicarboxylate transporter deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:615964 · OMIM 618384 · ICD-10 E75.2 · GARD 0018035
Start by learning the basics from an authoritative source, find a specialist or center that sees Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, filtered to your area.
Tomeko shows live, recruiting studies for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate from ClinicalTrials.gov on the hub.